Inhibition of Inducible Nitric Oxide Synthesis by Oxidized Lipoprotein(a) in a Murine Macrophage Cell Line
Overview
Affiliations
Increased plasma levels of human lipoprotein(a) (Lp(a)) are highly correlated with the development of atherosclerotic lesions. During our study, we investigated the effects of native and hypochlorite oxidized lipoprotein(a) (ox-Lp(a)) on nitric oxide production by the inducible nitric oxide synthase (iNOS) in lipopolysaccharide/interferon stimulated mouse macrophages (J774A.1). Ox-Lp(a) (0-2 microg/ml) induces a dose dependent inhibition of inducible nitric oxide synthesis. iNOS protein expression showed a dose dependent reduction as revealed by immunoblotting when cells were incubated with increasing amounts of ox-Lp(a). Ox-Lp(a) decreases iNOS mRNA synthesis as shown by reverse transcription-polymerase chain reaction. Ox-Lp(a) induced iNOS inhibition might contribute to the development of atherosclerotic lesions by reducing the anti-atherogenic effects of nitric oxide.
Lipoprotein(a): Just an Innocent Bystander in Arterial Hypertension?.
Brosolo G, Da Porto A, Marcante S, Picci A, Capilupi F, Capilupi P Int J Mol Sci. 2023; 24(17).
PMID: 37686169 PMC: 10487946. DOI: 10.3390/ijms241713363.
Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment.
Lampsas S, Xenou M, Oikonomou E, Pantelidis P, Lysandrou A, Sarantos S Molecules. 2023; 28(3).
PMID: 36770634 PMC: 9918959. DOI: 10.3390/molecules28030969.
Mueller P, Yerkes E, Bergstrom P, Rosario S, Hay J, Pamir N Sci Rep. 2022; 12(1):9138.
PMID: 35650291 PMC: 9160242. DOI: 10.1038/s41598-022-13040-4.
Lin Y, Yeh C, Kuo K, Fong I, Yadav V, Kounis N Oxid Med Cell Longev. 2022; 2022:9964689.
PMID: 35096275 PMC: 8793348. DOI: 10.1155/2022/9964689.
Emerging insights into the relationship between hyperlipidemia and the risk of diabetic retinopathy.
Chou Y, Ma J, Su X, Zhong Y Lipids Health Dis. 2020; 19(1):241.
PMID: 33213461 PMC: 7677820. DOI: 10.1186/s12944-020-01415-3.